The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.La présente invention concerne des anticorps anti-NGF tels que des anticorps antagonistes anti-NGF, et des polynucléotides les codant. L'invention concerne également l'utilisation de tels anticorps et/ou polynucléotides pour le traitement et/ou la prévention des douleurs, (postopératoires, polyarthrite rhumatoïde, arthrose).